Q32 Bio

Yahoo Finance • 2 months ago

Q32 Bio August 2025 slides: Bempikibart shows durable response in alopecia areata

Introduction & Market Context Q32 Bio Inc (NASDAQ:QTTB) presented its corporate overview in August 2025, highlighting the company’s focus on immune therapeutics with a primary emphasis on its lead candidate Bempikibart for alopecia areata... Full story

Yahoo Finance • 3 months ago

Q32 Bio names interim chief medical officer

* Clinical-stage biotechnology company Q32 Bio (NASDAQ:QTTB [https://seekingalpha.com/symbol/QTTB]) appointed [https://seekingalpha.com/pr/20147073-q32-bio-appoints-adrien-sipos-m-d-ph-d-as-interim-chief-medical-officer] Adrien Sipos,... Full story